Your browser doesn't support javascript.
loading
Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis: A Subgroup Analysis of the Phase 3 TOWER Study.
Qiu, Wei; Huang, De-Hui; Hou, Shi-Fang; Zhang, Mei-Ni; Jin, Tao; Dong, Hui-Qing; Peng, Hua; Zhang, Chao-Dong; Zhao, Gang; Huang, Yi-Ning; Zhou, Dong; Wu, Wei-Ping; Wang, Bao-Jun; Li, Ji-Mei; Zhang, Xing-Hu; Cheng, Yan; Li, Hai-Feng; Li, Ling; Lu, Chuan-Zhen; Zhang, Xu; Bu, Bi-Tao; Dong, Wan-Li; Fan, Dong-Sheng; Hu, Xue-Qiang; Xu, Xian-Hao.
Afiliación
  • Qiu W; Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510000, China.
  • Huang DH; Department of Neurology, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
  • Hou SF; Department of Neurology, Beijing Hospital, Beijing 100730, China.
  • Zhang MN; Department of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
  • Jin T; Department of Neurology, The First Hospital of Jilin University, Changchun, Jilin 130012, China.
  • Dong HQ; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
  • Peng H; Department of Neurology, Shanghai Chang Zheng Hospital, Shanghai 200003, China.
  • Zhang CD; Department of Neurology, The First Hospital of China Medical University, Shenyang, Liaoning 110000, China.
  • Zhao G; Department of Neurology, Fourth Military Medical University, Xi'an, Shaanxi 710001, China.
  • Huang YN; Department of Neurology, Peking University First Hospital, Beijing 100034, China.
  • Zhou D; Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
  • Wu WP; Department of Neurology, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
  • Wang BJ; Department of Neurology, Baotou Central Hospital, Baotou, Inner Mongolia 014040, China.
  • Li JM; Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100000, China.
  • Zhang XH; Department of Neurology, Beijing Tian Tan Hospital, Capital Medical University, Beijing 100050, China.
  • Cheng Y; Department of Neurology, Tianjin Medical University General Hospital, Tianjin 300052, China.
  • Li HF; Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
  • Li L; Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
  • Lu CZ; Department of Neurology, Hua Shan Hospital of the Shanghai Fudan University Medical College, Shanghai 200040, China.
  • Zhang X; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
  • Bu BT; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
  • Dong WL; Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, China.
  • Fan DS; Department of Neurology, Beijing Hospital, National Center of Gerontology, Beijing 100083, China.
  • Hu XQ; Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510000, China.
  • Xu XH; Department of Neurology, Beijing Hospital, Beijing 100730, China.
Chin Med J (Engl) ; 131(23): 2776-2784, 2018 Dec 05.
Article en En | MEDLINE | ID: mdl-30511679

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Toluidinas / Crotonatos / Inmunosupresores / Esclerosis Múltiple Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Chin Med J (Engl) Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Toluidinas / Crotonatos / Inmunosupresores / Esclerosis Múltiple Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Chin Med J (Engl) Año: 2018 Tipo del documento: Article País de afiliación: China